TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Belach Bioteknik AB
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
4,953
|
21,253
|
10,305 |
Financial expenses |
24
|
25
|
8 |
Earnings before taxes |
-1,325
|
3,795
|
33 |
EBITDA |
-1,238
|
3,884
|
120 |
Total assets |
7,677
|
9,501
|
14,019 |
Current assets |
5,879
|
9,174
|
14,003 |
Current liabilities |
1,093
|
1,598
|
9,246 |
Equity capital |
6,367
|
7,465
|
4,773 |
- share capital |
336
|
334
|
364 |
Employees (average) |
5
![]() |
5
|
6 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
82.9%
|
78.6%
|
34.0% |
Turnover per employee |
991
|
4,251
|
1,718 |
Profit as a percentage of turnover |
-26.8%
|
17.9%
|
0.3% |
Return on assets (ROA) |
-16.9%
|
40.2%
|
0.3% |
Current ratio |
537.9%
|
574.1%
|
151.4% |
Return on equity (ROE) |
-20.8%
|
50.8%
|
0.7% |
Change turnover |
-16,410
|
11,783
|
-1,950 |
Change turnover % |
-77%
|
124%
|
-16% |
Chg. No. of employees |
0
|
-1
|
0 |
Chg. No. of employees % |
0%
|
-17%
|
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.